Biologics CDMO Target biotech firms seeking end-to-end CDMO services for biologics from preclinical development to GMP manufacturing (mammalian and microbial), with capabilities in CHO line development and analytical development for standard and non-standard formats.

Quality Compliance Leverage MBH’s EU GMP and AIFA-aligned quality system as a selling point to Biotech companies requiring compliant manufacturing and robust quality oversight for regulatory readiness.

Growth Engine Position MBH as a fast-growing, agile partner that can reduce development timelines and accelerate scale-up to GMP, appealing to small- to mid-size biotechs needing speed without compromising quality.

Global Collaboration Highlight potential for collaboration with larger pharmaceutical groups through MBH’s integrated services to support late-stage development and manufacturing expansions, leveraging its Rome-area operations as a regional hub.

Digital & Compliance Tools Utilize MBH’s tech stack and data governance tools (OneTrust, Adobe Experience Manager, Google tools) to promise streamlined documentation, audit readiness, and customer-centric digital experiences for partner programs.